| EMA number | EMEA/H/C/000246 |
| ATC code | J05AP01 |
| Authorisation | 6 May 1999 |
| Withdrawn | 18 October 2023 |
| Revision | 39 |
Rebetol is indicated in combination with other medicinal products for the treatment of chronic hepatitis C (CHC) in adults. Rebetol is indicated in combination with other medicinal products for the treatment of chronic hepatitis C (CHC) for paediatric patients (children 3 years of age and older and adolescents) not previously treated and without liver decompensation.